News Releases

• Jan. 9, 2012 – Uptake Medical Announces Successful Completion of Series C Financing
• Dec. 21, 2011 - Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema
• Nov. 29, 2011 – Uptake Medical Announces First Commercial Use of InterVapor for Patients with Severe Emphysema
• Sept. 26, 2011 – Uptake Medical Receives CE Mark for InterVapor – Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema – And Announces Positive Clinical Results
• Sept. 6, 2011 – Uptake Medical Expands Executive Team, Announces European General Manager Lloyd Mencinger
• March 1, 2011 – Uptake Medical Announces Scott Huennekens Elected to Board of Directors
• Nov. 1, 2010 – Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
• July 7, 2010 – Uptake Medical Completes Series B Financing Round for $17.5 Million
• Dec. 21, 2009 – Uptake Medical Announces First Patients Treated in Clinical trial for Patients with Heterogeneous Emphysema (the VAPOR trial)

Fact Sheet 

Media Contact:
Deborah Jones
Strategies (for Uptake Medical)
(714) 957-8880, ext. 113
deborah@strategiesadpr.com